STOCK TITAN

[SCHEDULE 13G/A] GH Research PLC SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Terwey Theis reports beneficial ownership of 4,692,903 ordinary shares of GH Research PLC, representing 7.6% of the outstanding class based on 62,029,395 shares outstanding as of June 30, 2025. The disclosure shows the reporting person is a German citizen and holds sole voting and sole dispositive power over all reported shares, with no shared voting or dispositive arrangements.

This Schedule 13G amendment documents a substantial ownership position above the 5% threshold that requires public disclosure; it does not specify transactions, motives, or any arrangements with other holders.

Terwey Theis dichiara la titolarità beneficiaria di 4,692,903 azioni ordinarie di GH Research PLC, pari al 7.6% della classe in circolazione su un totale di 62,029,395 azioni in circolazione al 30 giugno 2025. L'informativa indica che il soggetto segnalante è cittadino tedesco e detiene l'esclusivo potere di voto e l'esclusivo potere dispositario su tutte le azioni dichiarate, senza accordi di voto o disposizioni condivise.

Questo emendamento al Schedule 13G documenta una posizione di partecipazione sostanziale superiore alla soglia del 5% che richiede comunicazione pubblica; non specifica operazioni, motivazioni o eventuali accordi con altri detentori.

Terwey Theis declara la titularidad beneficiaria de 4,692,903 acciones ordinarias de GH Research PLC, lo que representa el 7.6% de la clase en circulación sobre 62,029,395 acciones en circulación al 30 de junio de 2025. La comunicación indica que la persona informante es ciudadano alemán y posee poder exclusivo de voto y poder exclusivo de disposición sobre todas las acciones declaradas, sin acuerdos compartidos de voto o disposición.

Esta enmienda al Schedule 13G documenta una posición de propiedad sustancial por encima del umbral del 5% que exige divulgación pública; no especifica transacciones, motivos ni acuerdos con otros tenedores.

Terwey Theis는 GH Research PLC의 4,692,903 보통주에 대한 실질적 소유권을 보고하며, 이는 2025년 6월 30일 기준 발행주식수 62,029,395주를 기준으로 발행주식의 7.6%에 해당합니다. 공시는 보고인이 독일 시민임을 표시하며 보고된 모든 주식에 대해 단독 의결권 및 단독 처분권을 보유하고 있으며, 공동 의결권 또는 처분 권한은 없다고 명시합니다.

이 Schedule 13G 수정보고서는 공시가 요구되는 5% 기준을 초과하는 상당한 소유 지분을 문서화한 것이며, 거래 내역, 보유 동기 또는 다른 보유자와의 어떠한 합의도 명시하지 않습니다.

Terwey Theis déclare la propriété bénéficiaire de 4,692,903 actions ordinaires de GH Research PLC, représentant 7.6% de la catégorie en circulation sur la base de 62,029,395 actions en circulation au 30 juin 2025. La déclaration indique que la personne déclarante est citoyen allemand et détient le pouvoir de vote exclusif et le pouvoir de disposition exclusif sur toutes les actions déclarées, sans arrangements de vote ou de disposition partagés.

Cette modification du Schedule 13G documente une position de participation substantielle dépassant le seuil de 5% qui nécessite une divulgation publique ; elle ne précise ni transactions, ni motifs, ni arrangements avec d'autres détenteurs.

Terwey Theis meldet die wirtschaftliche Eigentümerschaft von 4,692,903 Stammaktien der GH Research PLC, was 7,6% der ausstehenden Klasse entspricht, basierend auf 62,029,395 ausstehenden Aktien zum 30. Juni 2025. Die Offenlegung gibt an, dass die meldende Person deutscher Staatsbürger ist und über alle gemeldeten Aktien alleiniges Stimmrecht und alleiniges Verfügungsrecht besitzt, ohne geteilte Stimm- oder Verfügungsvereinbarungen.

Diese Änderung zum Schedule 13G dokumentiert eine erhebliche Beteiligung oberhalb der 5%-Schwelle, die eine öffentliche Offenlegung erfordert; sie nennt keine Transaktionen, Motive oder Absprachen mit anderen Inhabern.

Positive
  • Beneficial ownership above 5%: 4,692,903 shares representing 7.6% of the class (material disclosure)
  • Sole voting and dispositive power over all reported shares, indicating clear, individual control of the position
Negative
  • Concentration risk: a single holder with sole voting and dispositive authority could exert outsized influence
  • No transactional detail provided, so the filing does not clarify whether the position is increasing, decreasing, or strategic

Insights

TL;DR: A disclosed 7.6% stake with sole voting and dispositive power is material but neutral absent transactional context.

Theis Terwey's 4.69 million-share holding crosses the reporting threshold and is therefore material for investors to monitor. Sole voting and dispositive authority indicates direct control over disposition and voting of these shares, which can affect shareholder votes or potential block trades. The filing contains no indication of coordinated group activity, acquisitions, or changes to the position, so the immediate market impact is informational rather than transactional.

TL;DR: Concentrated, disclosed stake with sole control raises governance relevance but provides no signal on intent.

A 7.6% ownership stake with exclusive voting and dispositive power is governance-relevant because it concentrates influence in a single holder. That concentration could shape corporate votes or strategic outcomes if exercised, yet the filing does not reveal any plans to engage with management or propose changes. Without evidence of an activist intent or coordinated group, the disclosure is a routine material ownership update.

Terwey Theis dichiara la titolarità beneficiaria di 4,692,903 azioni ordinarie di GH Research PLC, pari al 7.6% della classe in circolazione su un totale di 62,029,395 azioni in circolazione al 30 giugno 2025. L'informativa indica che il soggetto segnalante è cittadino tedesco e detiene l'esclusivo potere di voto e l'esclusivo potere dispositario su tutte le azioni dichiarate, senza accordi di voto o disposizioni condivise.

Questo emendamento al Schedule 13G documenta una posizione di partecipazione sostanziale superiore alla soglia del 5% che richiede comunicazione pubblica; non specifica operazioni, motivazioni o eventuali accordi con altri detentori.

Terwey Theis declara la titularidad beneficiaria de 4,692,903 acciones ordinarias de GH Research PLC, lo que representa el 7.6% de la clase en circulación sobre 62,029,395 acciones en circulación al 30 de junio de 2025. La comunicación indica que la persona informante es ciudadano alemán y posee poder exclusivo de voto y poder exclusivo de disposición sobre todas las acciones declaradas, sin acuerdos compartidos de voto o disposición.

Esta enmienda al Schedule 13G documenta una posición de propiedad sustancial por encima del umbral del 5% que exige divulgación pública; no especifica transacciones, motivos ni acuerdos con otros tenedores.

Terwey Theis는 GH Research PLC의 4,692,903 보통주에 대한 실질적 소유권을 보고하며, 이는 2025년 6월 30일 기준 발행주식수 62,029,395주를 기준으로 발행주식의 7.6%에 해당합니다. 공시는 보고인이 독일 시민임을 표시하며 보고된 모든 주식에 대해 단독 의결권 및 단독 처분권을 보유하고 있으며, 공동 의결권 또는 처분 권한은 없다고 명시합니다.

이 Schedule 13G 수정보고서는 공시가 요구되는 5% 기준을 초과하는 상당한 소유 지분을 문서화한 것이며, 거래 내역, 보유 동기 또는 다른 보유자와의 어떠한 합의도 명시하지 않습니다.

Terwey Theis déclare la propriété bénéficiaire de 4,692,903 actions ordinaires de GH Research PLC, représentant 7.6% de la catégorie en circulation sur la base de 62,029,395 actions en circulation au 30 juin 2025. La déclaration indique que la personne déclarante est citoyen allemand et détient le pouvoir de vote exclusif et le pouvoir de disposition exclusif sur toutes les actions déclarées, sans arrangements de vote ou de disposition partagés.

Cette modification du Schedule 13G documente une position de participation substantielle dépassant le seuil de 5% qui nécessite une divulgation publique ; elle ne précise ni transactions, ni motifs, ni arrangements avec d'autres détenteurs.

Terwey Theis meldet die wirtschaftliche Eigentümerschaft von 4,692,903 Stammaktien der GH Research PLC, was 7,6% der ausstehenden Klasse entspricht, basierend auf 62,029,395 ausstehenden Aktien zum 30. Juni 2025. Die Offenlegung gibt an, dass die meldende Person deutscher Staatsbürger ist und über alle gemeldeten Aktien alleiniges Stimmrecht und alleiniges Verfügungsrecht besitzt, ohne geteilte Stimm- oder Verfügungsvereinbarungen.

Diese Änderung zum Schedule 13G dokumentiert eine erhebliche Beteiligung oberhalb der 5%-Schwelle, die eine öffentliche Offenlegung erfordert; sie nennt keine Transaktionen, Motive oder Absprachen mit anderen Inhabern.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



Terwey Theis H
Signature:/s/ Theis Terwey
Name/Title:Theis Terwey
Date:08/14/2025

FAQ

Who filed the Schedule 13G/A for GH Research (GHRS)?

The Schedule 13G/A was filed by Theis Terwey, a citizen of Germany, as the reporting person.

How many GH Research (GHRS) shares does the reporting person own?

The reporting person beneficially owns 4,692,903 shares of GH Research ordinary shares.

What percentage of GH Research (GHRS) does this holding represent?

The position represents 7.6% of the outstanding ordinary shares, based on 62,029,395 shares outstanding as of June 30, 2025.

Does the filer share voting or dispositive power over these GHRS shares?

No. The filer reports sole voting power and sole dispositive power over all 4,692,903 shares and reports no shared power.

Does the filing indicate holdings on behalf of another person or a group?

No. The filing states not applicable for holdings on behalf of another person and no group membership is identified.
Gh Research Plc

NASDAQ:GHRS

GHRS Rankings

GHRS Latest News

GHRS Latest SEC Filings

GHRS Stock Data

895.70M
42.51M
31.47%
70.41%
3.54%
Biotechnology
Healthcare
Link
Ireland
Dublin